Each capsule contains 12mg of ivermectin. Our “Broad-Spectrum Antiparasitic” formulation provides a potent, single-dose option for effective parasite control, leveraging ivermectin’s established efficacy against a wide array of helminths and ectoparasites while minimizing dosing frequency for greater convenience and compliance in treatment regimens. Ivermectin, a semi-synthetic derivative of avermectin produced by the soil bacterium Streptomyces avermitilis, exerts its therapeutic effects primarily by binding to glutamate-gated chloride channels and gamma-aminobutyric acid (GABA) receptors in invertebrate nerve and muscle cells, leading to hyperpolarization, paralysis, and death of the parasites without significant impact on mammalian hosts due to differences in channel pharmacology. This mechanism also extends to modulating host immune responses, reducing inflammation associated with parasitic infections, and supporting clearance of microfilariae in conditions like onchocerciasis and lymphatic filariasis, while its broad activity covers strongyloidiasis, scabies, and head lice for comprehensive ecto- and endoparasite management. Ivermectin also is being used for anti-cancer properties, as well as improving insulin resistance. An important part of Chronic Fatigue Syndrome.